≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Molar incisor enamel hypoplasia, with caries

Endpoint Browser PheWeb

K11_MIH_CARIES

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

  • K11_CARIES
12851

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

3 out of 7 registries used, show all original rules.

266

4. Check minimum number of events

None

266

5. Include endpoints

266

6. Filter based on genotype QC (FinnGen only)

266

Control definitions (FinnGen only)

Control conditions
not K11_CARIES

Extra metadata

First used in FinnGen datafreeze
DF10

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2382 1118 1261
Only index persons 1584 754 830
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.04
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 8.86 8.93 8.74
Only index persons 11.23 11.43 11.04

-FinnGen-

Key figures

All Female Male
Number of individuals 266 135 131
Unadjusted period prevalence (%) 0.05 0.05 0.06
Median age at first event (years) 8.41 8.84 7.97

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
232
Matched controls
2320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
551.6
236.3
218
63
127
Kela drug reimbursment
Transplant complication
142.2
92.6
94
11
Z2221
NOMESCO Finland
Medical doctor
23.8
90.6
198
455
H02AB09
ATC
hydrocortisone; systemic
33.3
87.8
120
72
K02.0
ICD-10 Finland
Caries limited to enamel
22.3
85.5
200
508
WX404
NOMESCO Finland
Intravenous generell anesthesy
20.1
83.9
194
469
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
48.7
83.2
101
36
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
38.6
79.2
102
46
K03.66
ICD-10 Finland
Tooth plaque
16.0
76.7
159
277
EBA15
NOMESCO Finland
Extraction of large number of teeth
78.5
74.4
82
16
ZXE10
NOMESCO Finland
More than one and less than three hours
15.3
72.4
188
505
H02AB04
ATC
methylprednisolone; systemic
44.9
71.5
88
31
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
32.2
69.0
93
47
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
101.4
66.7
71
10
Z94.0
ICD-10 Finland
Kidney transplant status
110.4
66.5
70
9
ZXD05
NOMESCO Finland
Urgent procedure
12.7
66.2
158
334
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
17.1
63.9
112
120
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
13.6
63.7
131
201
R4110
NOMESCO Finland
Physiotherapy
11.3
61.5
167
428
WX408
NOMESCO Finland
General anesthesy, balanced
12.2
61.2
188
601
Z3226
NOMESCO Finland
Physiotherapist
11.3
60.6
175
496
ZX120
NOMESCO Finland
Intravenous
17.5
60.3
103
101
L04AX01
ATC
azathioprine; systemic
28.7
59.9
83
44
Z2446
NOMESCO Finland
Social worker
10.4
56.9
150
348
ZXD10
NOMESCO Finland
Scheduled procedure
11.8
55.8
196
733
A11CC03
ATC
alfacalcidol; systemic
47.9
54.8
66
19
ZXE00
NOMESCO Finland
One hour or less
11.4
52.4
199
803
205
Kela drug reimbursment
Chronic hypertension
39.6
50.9
64
22
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
63.9
50.8
58
12
XF602
NOMESCO Finland
Bloodpressure monitoring
40.6
50.4
63
21
ZXE20
NOMESCO Finland
More than three and less than five hours
11.3
50.1
109
169
GD1AA
NOMESCO Finland
Thorax X-ray examination
8.5
49.3
157
457
C08CA01
ATC
amlodipine; oral
34.8
47.8
62
24
Z3231
NOMESCO Finland
Registered nurse
9.7
47.4
195
818
L04AD01
ATC
ciclosporin; systemic
31.5
47.3
63
27
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
26.6
47.1
66
34
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
81.1
46.4
51
8
Z01.0
ICD-10 Finland
Examination of eyes and vision
8.1
45.5
134
333
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.9
44.9
137
357
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
9.6
44.9
107
189
Z3229
NOMESCO Finland
Other healthcare associate professional
9.3
44.0
108
199
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
56.1
42.0
49
11
SAA04
NOMESCO Finland
Special inverstigation of mouth
8.6
42.0
109
217
SCE00
NOMESCO Finland
Fissure closure of tooth
7.2
41.9
143
424
L04AA06
ATC
mycophenolic acid; systemic
34.8
41.8
54
20
TPH04
NOMESCO Finland
Cathetrisation of vein
8.4
41.7
111
229
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
14.5
41.0
73
71
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
14.3
40.7
73
72
L04AA01
ATC
[U] ciclosporin; systemic
165.1
40.2
41
*
602
Kela drug reimbursment
Children's severe malnutrition
14.7
39.7
70
66
XF400
NOMESCO Finland
ECG with 12 standard connections
6.9
39.3
132
373
ZXA00
NOMESCO Finland
Right side
8.4
39.1
101
195
137
Kela drug reimbursment
Uraemia requiring dialysis
67.4
38.9
44
8
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
28.2
38.8
53
24
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
53.9
37.5
44
10
K06.18
ICD-10 Finland
Another gingival hyperplasia
46.1
37.2
45
12
C03CA01
ATC
furosemide; systemic
18.9
37.1
58
40
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
6.7
37.0
121
323
SAA03
NOMESCO Finland
Extended examination of mouth
11.6
36.3
216
1246
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
44.8
36.2
44
12
Z94.4
ICD-10 Finland
Liver transplant status
405.2
36.0
35
*
B03XA01
ATC
erythropoietin; parenteral
61.8
35.8
41
8
Z2445
NOMESCO Finland
Psychologist
6.9
35.2
107
255
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
90.1
35.0
38
5
TPH07
NOMESCO Finland
Cathetrisation of artery
8.9
35.0
83
136
A12AA04
ATC
calcium carbonate; oral
49.3
34.4
41
10
B05DA
ATC
Isotonic solutions
75.2
34.2
38
6
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.5
34.0
111
288
A41.9
ICD-10 Finland
Sepsis, unspecified
17.2
34.0
55
41
FM2CE
NOMESCO Finland
NA
8.2
33.8
85
152
WX882
NOMESCO Finland
High dependency care
7.2
33.8
97
211
C08CA02
ATC
felodipine; oral
106.1
33.8
36
*
RD210
NOMESCO Finland
NA
8.1
33.2
84
151
K03.00
ICD-10 Finland
Approximal wear
18.3
33.0
52
36
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
25.7
32.9
46
22
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
10.3
32.2
68
90
R50.9
ICD-10 Finland
Fever, unspecified
5.5
31.5
128
423
5AB14
NOMESCO Finland
NA
184.6
31.5
32
*
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
12.4
31.3
59
62
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
14.6
30.6
53
46
V03AG01
ATC
sodium cellulose phosphate; systemic
58.5
30.3
35
7
WW500
NOMESCO Finland
Blood transfusion
18.7
30.2
47
31
ZXA10
NOMESCO Finland
Bilateral
5.8
30.2
106
292
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
42.3
29.4
36
10
Z49.2
ICD-10 Finland
Other dialysis
56.6
29.3
34
7
KAC00
NOMESCO Finland
Nephrectomy
56.6
29.3
34
7
ZXA05
NOMESCO Finland
Left side
7.1
29.2
81
163
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
88.7
28.5
31
*
K03.64
ICD-10 Finland
Dental calculus supragingival
4.9
28.5
142
565
B05DB
ATC
Hypertonic solutions
164.9
28.3
29
*
XW000
NOMESCO Finland
Bone marrow biopsy
16.1
28.0
46
35
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.6
27.9
99
271
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
25.6
26.6
37
17
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
6.1
26.5
83
193
Z99.2
ICD-10 Finland
Dependence on renal dialysis
82.2
26.5
29
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.9
26.2
113
378
C07AB02
ATC
metoprolol; systemic
14.4
26.1
45
38
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
40.9
26.0
32
9
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.6
26.0
60
90
TK800
NOMESCO Finland
Hemodialysis
79.1
25.4
28
*
BE00A
NOMESCO Finland
NA
63.3
24.6
28
5
C03DA01
ATC
spironolactone; oral
14.4
24.5
42
35
TPX10
NOMESCO Finland
Implantation of vascular injection port
22.7
24.3
35
18
N18.8
ICD-10 Finland
Other chronic renal failure
27.2
24.3
33
14
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
10.0
24.0
50
62
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
38.0
24.0
30
9
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.3
23.8
70
148
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
12.1
23.6
44
44
ZX199
NOMESCO Finland
Other rote
21.9
23.4
34
18
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
5.4
23.4
82
214
Z49.1
ICD-10 Finland
Extracorporeal dialysis
72.8
23.4
26
*
ZX121
NOMESCO Finland
Central venous catheter
29.6
23.3
31
12
XX4AW
NOMESCO Finland
NA
10.6
23.0
46
53
A02BC01
ATC
omeprazole; systemic
6.2
23.0
69
149
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
6.5
22.9
65
130
J05AB01
ATC
aciclovir; systemic
7.5
22.7
57
96
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
6.6
22.7
64
127
XA800
NOMESCO Finland
Neuropsychological investigation
5.8
22.6
72
167
C09CA01
ATC
losartan; oral
25.3
22.4
31
14
C09AA02
ATC
enalapril; systemic
14.4
22.3
38
31
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
14.4
22.3
38
31
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
88.9
22.1
24
*
TAB00
NOMESCO Finland
Lumbar puncture
10.7
21.8
43
48
RS220
NOMESCO Finland
NA
11.3
21.4
41
43
BC00A
NOMESCO Finland
NA
41.5
21.3
26
7
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
13.5
20.6
36
31
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
6.4
20.5
58
114
Z94.1
ICD-10 Finland
Heart transplant status
114.9
19.9
21
*
RS221
NOMESCO Finland
NA
9.4
19.9
42
53
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.4
19.8
56
110
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
25.3
19.6
27
12
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.7
19.5
77
222
EB1WA
NOMESCO Finland
NA
60.4
19.3
22
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
21.0
19.2
28
15
V03AE01
ATC
polystyrene sulfonate; oral
109.0
18.9
20
*
K02.1
ICD-10 Finland
Caries of dentine
3.8
18.9
175
1036
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
19.7
18.8
28
16
B01AA03
ATC
warfarin; systemic
14.1
18.8
32
26
WX402
NOMESCO Finland
General anaesthesia
3.9
18.8
96
352
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
4.6
18.6
75
220
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.5
18.4
138
686
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
29.5
18.2
24
9
ZXE40
NOMESCO Finland
More than seven and less than nine hours
12.2
18.1
33
31
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.1
18.1
84
281
201
Kela drug reimbursment
Chronic cardiac insufficiency
14.2
17.7
30
24
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
8.6
17.6
39
53
TK820
NOMESCO Finland
Peritoneal dialysis
46.0
17.6
21
5
A05AA02
ATC
ursodeoxycholic acid; oral
17.8
17.5
27
17
WX110
NOMESCO Finland
Local anesthesy
4.2
17.2
197
1330
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.8
17.2
63
166
J05AB11
ATC
valaciclovir; oral
12.2
17.1
31
29
4AA09
NOMESCO Finland
NA
68.6
17.0
19
*
H02AB02
ATC
dexamethasone; systemic
18.1
17.0
26
16
K03.28
ICD-10 Finland
Other erosion of teeth
30.2
16.8
22
8
6BA02
NOMESCO Finland
NA
22.1
16.8
24
12
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.4
16.7
68
199
XX4BW
NOMESCO Finland
NA
17.1
16.6
26
17
ZXD20
NOMESCO Finland
Day surgery
4.8
16.5
60
156
ZX114
NOMESCO Finland
Intramuscular
16.1
16.3
26
18
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
3.9
16.3
79
271
B03XA02
ATC
darbepoetin alfa; parenteral
64.7
16.0
18
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.6
16.0
49
105
SDA02
NOMESCO Finland
Parodonthologic therapy
3.3
16.0
115
535
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
4.4
15.9
65
190
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
6.2
15.7
44
84
F43.8
ICD-10 Finland
Other reactions to severe stress
17.7
15.6
24
15
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
17.7
15.6
24
15
SFA10
NOMESCO Finland
Fillning on one surface of tooth
3.2
15.5
158
929
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
19.5
15.5
23
13
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.6
15.4
41
73
A49.9
ICD-10 Finland
Bacterial infection, unspecified
10.3
15.2
30
33
K03.29
ICD-10 Finland
Erosion of teeth occupational
34.3
15.1
19
6
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
13.2
15.0
26
22
L03AA02
ATC
filgrastim; parenteral
60.8
15.0
17
*
ZX131
NOMESCO Finland
Intrathecal
60.8
15.0
17
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
22.9
15.0
21
10
XF600
NOMESCO Finland
Bloodpressure measurement
3.9
14.8
71
238
WW200
NOMESCO Finland
Immunization
13.9
14.8
25
20
UDC00
NOMESCO Finland
Ear microscopy
4.9
14.6
51
126
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
20.8
14.5
21
11
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
15.8
14.4
23
16
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.0
14.4
147
845
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.6
14.1
194
1362
Z01.2
ICD-10 Finland
Dental examination
3.3
14.0
182
1221
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
8.4
14.0
31
42
RK220
NOMESCO Finland
NA
16.1
13.9
22
15
ZY010
NOMESCO Finland
Hospital outpatient
3.7
13.8
68
232
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
+∞
13.7
13
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
13.7
13
*
L01BB02
ATC
mercaptopurine; oral
19.7
13.6
20
11
TFJ02
NOMESCO Finland
Muscle biopsy of heart
148.3
13.6
14
*
J01MA02
ATC
ciprofloxacin; systemic
5.2
13.6
44
100
K07.24
ICD-10 Finland
Open bite
6.6
13.4
35
61
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.5
13.3
51
138
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
8.9
13.3
28
35
J02AC01
ATC
fluconazole; systemic
4.7
13.2
48
123
B07.9
ICD-10 Finland
Verruca simplex
6.5
13.2
35
62
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
53.2
13.0
15
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.8
12.8
60
195
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
7.5
12.7
30
45
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.8
12.7
127
701
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
26.0
12.7
17
7
WX002
NOMESCO Finland
Sedation and analgesia
4.4
12.5
48
130
RK110
NOMESCO Finland
NA
13.5
12.4
21
17
C10AA03
ATC
pravastatin; oral
39.9
12.4
15
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
11.0
12.3
23
23
JAH00
NOMESCO Finland
Laparotomy
19.4
12.3
18
10
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
19.4
12.3
18
10
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
19.4
12.3
18
10
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
3.1
12.2
84
361
B34.9
ICD-10 Finland
Viral infection, unspecified
4.2
12.2
49
138
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
9.8
12.1
24
27
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.8
12.0
19
13
C08CA05
ATC
nifedipine; systemic
49.4
12.0
14
*
A01AB09
ATC
miconazole; local oral
6.7
11.8
30
50
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
68.5
11.7
13
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.9
11.5
51
157
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
8.4
11.5
25
33
1AB02
NOMESCO Finland
NA
18.2
11.4
17
10
SFA40
NOMESCO Finland
Replacement of krone of tooth
7.3
11.4
27
41
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
11.2
82
365
XF622
NOMESCO Finland
Measurement of minute volume of heart
12.8
11.1
19
16
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
6.1
11.0
30
55
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.8
11.0
49
151
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
45.6
11.0
13
*
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
8.7
10.9
23
29
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
22.8
10.8
15
7
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
5.7
10.8
31
61
K65.0
ICD-10 Finland
Acute peritonitis
63.0
10.7
12
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
63.0
10.7
12
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
3.2
10.7
65
253
RS121
NOMESCO Finland
NA
8.9
10.6
22
27
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
10.5
10
*
YNB20
NOMESCO Finland
Storage of stem cells for transplant
+∞
10.5
10
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
8.1
10.5
23
31
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
34.3
10.4
13
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
34.3
10.4
13
*
RL140
NOMESCO Finland
NA
6.1
10.4
28
51
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
3.9
10.3
45
136
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.1
10.3
64
255
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
12.1
10.2
18
16
R4190
NOMESCO Finland
Nutritional therapy
3.0
10.2
67
277
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
7.6
10.1
23
33
RT150
NOMESCO Finland
NA
6.7
10.0
25
41
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.6
10.0
29
58
Z31.5
ICD-10 Finland
Genetic counselling
3.9
10.0
43
129
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
27.4
9.9
13
5
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.7
9.9
34
82
WX892
NOMESCO Finland
Monitored bed care
4.1
9.9
39
108
GD1AD
NOMESCO Finland
Thorax CT examination
14.2
9.8
16
12
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
14.2
9.8
16
12
A06AD11
ATC
lactulose; oral
5.9
9.7
27
51
1XC02
NOMESCO Finland
NA
57.5
9.7
11
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
7.2
9.7
23
35
TJD20
NOMESCO Finland
Change of gastrostomy tube
10.7
9.7
18
18
A02BC05
ATC
esomeprazole; systemic
4.1
9.7
39
110
R62.0
ICD-10 Finland
Delayed milestone
3.7
9.7
44
138
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.6
9.7
45
144
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.0
9.6
40
116
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.7
9.6
27
52
XF404
NOMESCO Finland
Ambulatory ECG
4.3
9.6
36
95
SAB02
NOMESCO Finland
Oral and dental health check by dental hygienist or dental assistant
0.4
9.5
46
934
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
13.1
9.5
16
13
130
Kela drug reimbursment
Malignant tumour
13.1
9.5
16
13
J01FF01
ATC
clindamycin; systemic
4.2
9.5
37
101
WX704
NOMESCO Finland
Intubation
5.4
9.5
28
57
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
31.5
9.5
12
*
WW409
NOMESCO Finland
Other aferesis
31.5
9.5
12
*
3A013
NOMESCO Finland
NA
104.1
9.5
10
*
61
HP
Catheterization and pressure measurement of the left side of the heart
104.1
9.5
10
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
104.1
9.5
10
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.5
9.5
34
86
H52.0
ICD-10 Finland
Hypermetropia
4.6
9.5
33
81
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
2.4
9.4
131
816
N19
ICD-10 Finland
Unspecified kidney failure
+∞
9.4
9
*
783
NOMESCO Finland
NA
+∞
9.4
9
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.0
9.4
62
254
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
5.0
9.4
30
67
A04AA01
ATC
ondansetron; systemic, rectal
5.3
9.4
28
58
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.8
9.4
23
37
TQW99
NOMESCO Finland
Other minor procedure on skin
8.3
9.4
20
26
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.5
9.3
46
154
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
14.5
9.3
15
11
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.6
9.3
21
30
B01.9
ICD-10 Finland
Varicella without complication
6.0
9.2
25
46
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
9.7
9.2
18
20
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
6.6
9.2
23
38
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
16.4
9.2
14
9
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
38.3
9.1
11
*
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
19.6
9.0
13
7
RK230
NOMESCO Finland
NA
11.4
8.9
16
15
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
3.0
8.9
57
229
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.3
8.9
135
867
K00.68
ICD-10 Finland
Other disturbance in the tooth eruption
4.4
8.8
32
82
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.2
8.7
15
13
UJF32
NOMESCO Finland
Coloscopy
4.4
8.7
31
78
I15.8
ICD-10 Finland
Other secondary hypertension
17.1
8.7
13
8
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
13.4
8.5
14
11
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
93.3
8.5
9
*
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
93.3
8.5
9
*
L04AA05
ATC
[U] tacrolimus; systemic
93.3
8.5
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.3
8.5
119
732
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.6
8.4
24
47
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
+∞
8.4
8
*
ZX196
NOMESCO Finland
NA
+∞
8.4
8
*
AA1AD
NOMESCO Finland
CT of head and brain
4.5
8.4
29
71
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.9
8.3
34
97
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
8.0
8.3
18
24
RK320
NOMESCO Finland
NA
15.2
8.3
13
9
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.3
8.3
19
28
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.6
8.2
17
21
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
18.0
8.2
12
7
R5120
NOMESCO Finland
Preparation of an aid
34.7
8.1
10
*
N18.0
ICD-10 Finland
End-stage renal disease
34.7
8.1
10
*
324
NOMESCO Finland
NA
34.7
8.1
10
*
ZX197
NOMESCO Finland
NA
34.7
8.1
10
*
1XX02
NOMESCO Finland
NA
34.7
8.1
10
*
3A077
NOMESCO Finland
NA
34.7
8.1
10
*
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
23.0
8.1
11
5
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
4.1
8.1
31
84
A08.0
ICD-10 Finland
Rotaviral enteritis
6.5
8.0
20
33
UKC02
NOMESCO Finland
Cystoscopy
6.5
8.0
20
33
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.4
8.0
40
135
P85
ICPC
Mental retardation
7.4
7.9
18
26
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
6.0
7.9
21
38
TK823
NOMESCO Finland
Peritoneal permeability analysis
46.6
7.8
9
*
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
46.6
7.8
9
*
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
46.6
7.8
9
*
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
46.6
7.8
9
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
46.6
7.8
9
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
46.6
7.8
9
*
J01MA12
ATC
levofloxacin; systemic
8.5
7.7
16
20
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
19.2
7.7
11
6
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.9
7.7
31
88
Z01.8
ICD-10 Finland
Other specified special examinations
2.6
7.5
58
260
H52.2
ICD-10 Finland
Astigmatism
4.6
7.5
25
59
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.2
7.5
28
74
RS210
NOMESCO Finland
NA
14.0
7.5
12
9
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
14.0
7.5
12
9
RK260
NOMESCO Finland
NA
14.0
7.5
12
9
B02.9
ICD-10 Finland
Zoster without complication
14.0
7.5
12
9
WW400
NOMESCO Finland
Plasmaferesis
82.6
7.5
8
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
82.6
7.5
8
*
K06.10
ICD-10 Finland
Gingival fibromatosis
82.6
7.5
8
*
JKD50
NOMESCO Finland
Hepatoportoenterostomy
82.6
7.5
8
*
TK810
NOMESCO Finland
Hemofiltration
82.6
7.5
8
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
82.6
7.5
8
*
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
2.9
7.4
49
199
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
7.2
7.4
17
25
J01EA01
ATC
trimethoprim; systemic
3.4
7.4
36
119
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.7
7.4
24
55
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
11.4
7.4
13
12
TJF80
NOMESCO Finland
Ostomy education
9.8
7.4
14
15
H66.9
ICD-10 Finland
Otitis media, unspecified
2.2
7.4
97
566
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
+∞
7.3
7
*
2AX05
NOMESCO Finland
NA
+∞
7.3
7
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.0
7.3
17
26
RS222
NOMESCO Finland
NA
5.1
7.2
22
47
Z85.6
ICD-10 Finland
Personal history of leukaemia
31.1
7.2
9
*
K05.11
ICD-10 Finland
Gingivitis (chronic) hyperplastic
31.1
7.2
9
*
31
HP
Congenital heart failure surgery
31.1
7.2
9
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
9.2
7.2
14
16
R11
ICD-10 Finland
Nausea and vomiting
3.0
7.1
43
164
Z01.9
ICD-10 Finland
Special examination, unspecified
6.7
7.1
17
27
A28
ICPC
Limited function/disability NOS
3.5
7.1
33
106
XX8XW
NOMESCO Finland
NA
14.4
7.0
11
8
NE1AA
NOMESCO Finland
Pelvis X-ray examination
6.5
6.9
17
28
JAF10
NOMESCO Finland
Repair of umbilical hernia
11.4
6.9
12
11
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
17.3
6.8
10
6
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
17.3
6.8
10
6
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
41.3
6.8
8
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
41.3
6.8
8
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
41.3
6.8
8
*
H26.3
ICD-10 Finland
Drug-induced cataract
41.3
6.8
8
*
R1260
NOMESCO Finland
Evaluation of communicative skills
6.8
6.8
16
25
RK224
NOMESCO Finland
NA
23.3
6.7
9
*
Q44.29
ICD-10 Finland
Atresia of bile ducts
23.3
6.7
9
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
8.2
6.7
14
18
XKD00
NOMESCO Finland
Uroflowmetry
3.8
6.7
27
77
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
6.7
62
305
TQW80
NOMESCO Finland
Local dermatologic skincare
10.5
6.6
12
12
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
10.5
6.6
12
12
K00.50
ICD-10 Finland
Dentinal dysplasia
10.5
6.6
12
12
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
6.5
6.6
16
26
F83
ICD-10 Finland
Mixed specific developmental disorders
3.6
6.6
29
89
ZX112
NOMESCO Finland
Subcutaneous
7.8
6.5
14
19
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.3
6.5
23
58
N02AX02
ATC
tramadol; systemic, rectal
3.4
6.5
30
96
IEP02
NOMESCO Finland
Child-centred family therapy
3.8
6.5
26
74
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
71.7
6.5
7
*
B05XA03
ATC
sodium chloride; parenteral
71.7
6.5
7
*
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
14.8
6.5
10
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.9
6.4
15
23
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
9.7
6.4
12
13
ZX100
NOMESCO Finland
Oral
11.5
6.4
11
10
RT160
NOMESCO Finland
NA
5.3
6.3
18
36
JJC50
NOMESCO Finland
Resection of transplanted liver
+∞
6.3
6
*
E42
ICD-10 Finland
Marasmic kwashiorkor
+∞
6.3
6
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
+∞
6.3
6
*
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
+∞
6.3
6
*
C01AA05
ATC
digoxin; systemic
+∞
6.3
6
*
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
27.5
6.3
8
*
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
3.4
6.3
29
93
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.2
6.3
79
445
L28
ICPC
Limited function/disability (L)
3.8
6.2
25
71
K07.20
ICD-10 Finland
Crossbite (anterior)(posterior)
3.3
6.2
30
99
G04BE03
ATC
sildenafil; oral
8.0
6.2
13
17
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
9.0
6.1
12
14
NF1DA
NOMESCO Finland
X-ray of hips
9.0
6.1
12
14
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.9
6.1
24
67
WX306
NOMESCO Finland
Lumbar epidural anesthesy
6.3
6.1
15
25
TDM10
NOMESCO Finland
Puncture of maxillary antrum
6.3
6.1
15
25
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
10.4
6.1
11
11
H53.0
ICD-10 Finland
Amblyopia ex anopsia
4.3
6.1
21
52
H01AC01
ATC
somatropin; parenteral
3.4
6.0
28
90
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
7.6
6.0
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
108
34
52.59
174.88
17.4
9.6
u/ml
76.3
4553.6
—
18
5
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
66
11
79.17
120.95
10.4
9.8
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
63
18
45.38
102.46
40.3
39.0
ug/l
128.8
137.9
0.15
57
18
(3026493) Urate [Moles/volume] in Serum or Plasma
122
148
14.32
101.76
12.6
4.5
umol/l
316.5
281.0
1.84
122
140
(3016244) Insulin [Units/volume] in Serum or Plasma
94
88
15.91
92.18
4.1
3.0
mu/l
13.4
33.5
1.39
94
80
(3022948) Iron [Moles/volume] in Serum or Plasma
151
278
11.20
90.19
8.3
2.5
umol/l
13.4
14.6
1.25
151
272
(4035726)
80
67
16.58
83.35
2.7
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
127
209
10.67
82.33
6.3
3.3
e9/l
59.9
61.7
0.19
106
121
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
88
96
13.15
77.35
4.2
1.6
u/ml
72.1
80.2
—
6
5
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
88
97
13.01
76.78
4.1
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
97
133
10.86
71.87
10.3
8.2
g/l
0.2
0.3
0.61
89
106
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
59
43
17.28
65.74
2.3
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
179
551
7.84
61.26
28.9
6.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
113
224
8.00
60.06
20.8
3.9
umol/l
6.1
6.4
0.07
101
177
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
93
154
8.71
58.03
4.0
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
92
155
8.51
56.41
4.0
1.5
u/ml
210.8
155.9
0.72
62
57
(40768446) Kidney Pathology biopsy report
43
23
22.02
55.34
3.3
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
156
465
6.66
53.66
9.9
3.1
mosm/kgh2o
610.0
617.3
0.14
149
392
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
58
8
91.73
53.48
5.7
3.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
51
42
14.73
52.65
3.3
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
58
60
12.04
51.81
3.9
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
54
51
12.98
51.20
4.9
2.5
ml/min/173m2
48.2
93.5
2.91
18
11
(3002032) Base excess in Venous blood by calculation
179
626
6.65
50.90
30.1
5.3
mmol/l
1.2
1.2
0.01
163
495
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
49
40
14.73
50.78
3.4
1.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
179
628
6.62
50.65
30.2
5.3
kpa
5.7
5.9
1.43
179
611
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
48
38
15.13
50.63
15.6
9.1
u/ml
0.3
0.4
1.04
32
24
(3024354) Oxygen [Partial pressure] in Venous blood
176
609
6.55
50.56
28.4
5.1
kpa
5.4
5.1
1.27
176
595
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
46
34
16.09
50.41
3.5
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
136
377
6.31
50.03
16.4
3.3
ph
7.4
7.4
2.06
30
41
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
55
9
76.22
49.44
7.0
8.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
55
9
76.22
49.44
6.6
8.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
151
468
6.12
48.77
12.5
3.0
e6/l
4.1
5.4
1.21
146
402
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
53
53
12.19
48.31
8.2
2.7
%
87.3
91.8
0.49
53
53
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
59
11.45
47.77
3.7
1.8
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
44
33
15.72
47.75
4.4
4.4
umol/l
20.3
22.1
0.90
44
33
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
53
9
72.76
47.31
7.8
8.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
209
878
7.40
47.20
27.6
6.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
110
264
6.37
46.92
11.4
3.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
141
424
5.92
46.77
7.3
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
84
155
7.43
46.71
3.8
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
84
157
7.33
46.09
3.7
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
151
487
5.83
46.03
8.3
2.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
39
27
16.69
44.08
1.9
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
136
430
5.40
41.63
8.3
3.3
e6/l
0.6
0.7
0.18
110
254
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
102
259
5.74
40.16
9.7
3.1
mg/l
3.3
2.4
0.22
88
177
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
114
319
5.48
40.13
2.0
1.7
mmol/l
1.2
1.2
0.23
114
299
(42870588) Differential panel, method unspecified - Blood
226
1112
7.81
39.94
30.0
6.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
87
192
6.22
39.92
4.0
2.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
50
60
9.99
39.77
6.6
2.7
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
52
66
9.51
39.61
6.3
2.6
%
67.9
70.3
0.27
52
66
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
42
11.97
39.55
2.4
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
172
679
5.31
39.52
14.9
3.8
e6/l
0.1
0.2
0.20
153
512
(3023323) Follitropin [Units/volume] in Serum or Plasma
83
178
6.30
39.19
3.2
2.4
iu/l
8.0
8.1
0.01
57
103
(3009214) Lutropin [Units/volume] in Serum or Plasma
88
201
6.02
38.82
3.3
2.4
u/l
4.8
4.6
0.07
62
113
(3011412) CD3 cells [#/volume] in Blood
52
68
9.23
38.66
6.3
2.6
e9/l
1.1
1.6
1.84
41
52
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
52
68
9.23
38.66
2.9
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
135
447
5.08
38.48
8.2
3.5
e6/l
1.9
1.7
0.16
109
274
(36304419) Bacteria [Presence] in Urine
171
683
5.18
38.41
14.8
3.7
—
—
—
0
0
(44806118)
45
49
10.81
38.38
3.3
1.6
—
—
—
0
0
(44790049)
45
49
10.81
38.38
3.3
1.6
—
—
—
0
0
(44790048)
45
49
10.81
38.38
3.3
1.6
—
—
—
0
0
(44790047)
45
49
10.81
38.38
3.3
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
51
66
9.29
38.21
6.5
2.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
32
20
17.98
37.93
16.8
4.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
161
635
4.87
36.17
8.3
3.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
41
43
11.05
35.82
2.8
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
154
591
4.79
35.76
25.0
5.9
mmol/l
1.1
1.1
0.11
123
408
(3009343) pH of Capillary blood
154
592
4.78
35.65
25.2
6.0
ph
7.4
7.4
—
21
10
(3002582) Erythrocytes [#/volume] in Urine
173
730
4.89
35.33
16.7
3.9
e6/l
11.7
21.1
1.33
157
557
(3052851) Hemolysis interference index of Serum or Plasma
53
79
8.10
35.22
5.5
3.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
175
750
4.87
34.88
17.6
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
117
372
4.81
34.46
11.4
3.7
inr
1.1
1.2
0.39
23
75
(3017181) Myelocytes/100 leukocytes in Blood
57
97
7.18
33.55
7.8
5.1
%
0.4
0.4
0.02
29
35
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
31
23
15.07
33.51
3.2
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
31
23
15.07
33.51
1.6
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
184
837
4.86
33.42
19.6
4.6
e6/l
14.3
43.9
2.36
156
569
(3048929) Epstein Barr virus Ab [Presence] in Serum
102
297
4.93
33.42
4.0
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
62
116
6.64
33.29
2.3
1.6
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
47
65
8.53
33.20
6.2
2.9
e6/l
192.8
411.0
2.73
36
50
(3002179) Metamyelocytes/100 leukocytes in Blood
53
86
7.42
32.56
7.0
4.8
%
0.3
0.4
0.13
24
25
(3022313) Gas panel - Capillary blood
139
523
4.45
32.41
25.6
5.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
64
128
6.24
32.06
3.4
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
28
12.81
31.37
2.8
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
53
91
7.00
30.82
7.7
5.2
%
0.0
0.0
0.00
25
28
(3024471) HLA-A [Type]
23
11
22.71
30.50
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
23
11
22.71
30.50
1.0
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
131
490
4.28
30.40
7.5
2.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
238
1386
7.75
30.23
35.6
7.0
e9/l
0.0
0.0
1.84
223
1118
(3001604) Monocytes [#/volume] in Blood
238
1388
7.73
30.12
35.6
7.0
e9/l
0.6
0.6
1.50
223
1121
(3013826) Glucose [Moles/volume] in Serum or Plasma
209
1103
5.14
29.79
23.9
5.1
mmol/l
5.6
6.3
10.43
204
1045
(3042936) Bacteria identified in Isolate by Culture
70
163
5.45
29.60
2.8
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
44
66
7.76
28.87
6.4
2.6
e6/l
453.3
573.8
0.69
34
53
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
43
63
7.92
28.79
6.6
2.7
%
26.1
25.0
0.22
43
63
(3013115) Eosinophils [#/volume] in Blood
238
1413
7.44
28.77
40.4
7.5
e9/l
0.2
0.2
0.65
226
1177
(3051611) Lipemic interference index of Serum or Plasma
35
40
9.89
28.57
6.4
3.9
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
44
67
7.64
28.48
6.4
2.6
e9/l
0.1
0.2
2.18
34
54
(3021901) Oxygen saturation in Capillary blood
37
46
9.15
28.33
16.1
5.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
238
1426
7.30
28.08
35.5
7.0
e9/l
2.2
2.3
0.94
227
1193
(3034770) Mitochondria Ab [Titer] in Serum
35
41
9.64
28.04
2.9
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
36
44
9.27
27.92
15.1
2.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
36
10.28
27.85
6.5
3.7
e9/l
3.2
2.8
0.58
33
36
(3051651) Icteric interference index of Serum or Plasma
33
36
10.28
27.85
6.5
4.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
33
8
46.68
27.44
4.1
2.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
227
1335
5.73
26.63
39.0
7.9
e9/l
0.0
0.0
0.97
207
987
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
33
39
9.48
26.22
8.4
3.6
%
48.8
49.1
0.04
33
39
(3021440) Promyelocytes/100 leukocytes in Blood
49
92
6.28
25.92
8.4
5.3
%
0.0
0.0
0.03
28
31
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
32
37
9.66
25.83
3.0
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
237
1468
6.58
25.38
43.1
7.8
e9/l
3.1
3.4
0.87
223
1193
(3015736) pH of Urine
142
622
3.73
25.08
10.5
2.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
19
13.11
23.16
2.6
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
36
55
7.38
23.09
20.7
7.5
mmol/l
1.2
1.2
0.40
36
45
(3007853) Bacteria identified in Skin by Aerobe culture
80
250
4.13
22.94
3.5
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
48
99
5.67
22.91
12.4
3.5
ng/l
219.3
158.1
0.38
48
93
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
128
553
3.52
22.55
3.8
3.8
mg/l
2.9
2.5
1.43
118
492
(3012501) Base excess in Blood by calculation
26
28
10.14
22.01
17.8
9.0
mmol/l
0.8
2.0
1.38
13
15
(3027315) Oxygen [Partial pressure] in Blood
26
28
10.14
22.01
17.8
9.0
kpa
10.8
8.3
3.68
26
28
(3013290) Carbon dioxide [Partial pressure] in Blood
26
28
10.14
22.01
17.8
9.0
kpa
4.8
4.9
0.29
26
28
(3026008) Bacteria identified in Urine by Culture
97
363
3.62
21.20
6.2
2.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
22
20
11.86
20.84
4.5
1.9
mg/l
78.0
66.3
0.34
22
20
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
24
27
9.63
19.64
1.8
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
42
7.60
19.41
7.6
2.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
57
157
4.33
19.13
3.1
2.2
nmol/l
9.8
7.9
0.74
46
114
(3037467) Urinalysis macro (dipstick) panel - Urine
199
1201
3.58
19.10
17.4
3.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
46
7.20
19.09
5.6
2.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
12
15.01
18.57
3.3
2.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
28
41
7.49
18.54
1.8
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
152
794
3.12
18.48
12.7
3.0
estimate
0.0
0.0
0.00
35
109
(3031040) Bacteria [#/volume] in Urine by Automated count
188
1111
3.34
18.37
16.2
3.3
e6/l
83.8
30.3
—
10
9
(3024928) Oxygen saturation in Venous blood
29
45
7.08
18.23
31.2
10.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
28
42
7.31
18.14
31.8
13.0
%
72.4
74.5
0.23
28
42
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
18
11.25
17.45
3.6
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
148
787
2.97
17.00
13.0
3.0
estimate
0.0
0.0
0.00
32
102
(3021601) Nitrite [Presence] in Urine by Test strip
148
788
2.96
16.94
18.0
4.4
estimate
0.0
0.0
0.00
35
112
(3045142) Bone marrow Pathology biopsy report
21
24
9.38
16.93
2.1
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
15
10
15.78
16.81
2.0
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
85
336
3.23
16.48
2.2
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
16
13
12.98
16.10
2.2
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
38
88
4.85
15.71
2.0
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
38
88
4.85
15.71
2.0
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
67
235
3.46
15.70
2.6
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
24
36
7.20
15.50
6.1
4.5
u/ml
2.8
5.2
0.50
24
36
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
14
12.05
15.39
3.9
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
0
+∞
14.70
3.3
0.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
18
21
9.09
14.23
1.5
1.5
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
22
33
7.15
14.18
2.1
2.9
umol/l
15.9
15.2
0.08
22
33
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
62
220
3.36
14.16
6.3
2.7
ng/l
856.6
1595.1
0.59
42
134
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
30
65
5.06
13.35
2.7
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
143
825
2.57
12.87
27.1
5.3
ml/min/173m2
97.4
113.1
4.12
92
455
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
17
21
8.55
12.84
1.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
17
21
8.55
12.84
1.0
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
17
21
8.55
12.84
1.0
1.4
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
17
21
8.55
12.84
1.0
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
17
21
8.55
12.84
1.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
17
21
8.55
12.84
1.0
1.4
—
—
—
0
0
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
15
16
9.84
12.61
1.7
2.0
mg/l
1.0
1.9
—
10
16
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
77
331
2.85
12.49
2.4
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
49
5.51
12.41
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
78
341
2.81
12.23
20.2
4.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
26
7.33
11.95
41.2
15.1
%
11.0
12.3
0.90
18
26
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
17
23
7.80
11.92
1.1
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
15
9.76
11.70
2.5
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
18
8.74
11.55
1.7
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
65
265
2.91
11.54
2.5
1.6
titre
196.9
750.7
2.18
13
43
(3029075) Extractable nuclear Ab panel - Serum
15
19
8.28
11.07
1.0
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
74
332
2.69
10.90
2.1
1.5
pmol/l
101.4
97.6
0.34
36
160
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
15
7
22.51
10.78
2.7
1.6
pg
32.3
32.9
—
15
7
(3002256) Pathology report gross observation
37
112
3.66
10.66
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
20
7.86
10.62
1.4
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
20
7.86
10.62
2.5
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
18
30
6.34
10.48
1.1
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
18
8.12
10.19
2.5
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
28
72
4.21
10.08
1.8
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
28
6.39
10.00
6.8
3.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
28
6.39
10.00
6.8
3.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
26
64
4.38
9.89
10.5
4.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
134
3.32
9.85
2.0
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
16
8.46
9.77
1.5
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
32
94
3.72
9.61
23.0
9.2
mmol/l
-0.6
-0.7
0.04
26
74
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
18
33
5.76
9.54
1.1
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
46
4.85
9.18
1.3
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
14
9
16.26
9.11
6.1
4.3
ug/l
193.9
231.8
—
14
9
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
27
73
3.99
9.09
26.4
10.9
mmol/l
23.6
23.5
0.06
27
73
(3032352) Blasts [#/volume] in Cerebral spinal fluid
13
7
19.36
9.00
13.2
4.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
84
435
2.35
8.92
2.5
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
257
2240
5.22
8.92
68.4
11.3
%
36.7
39.4
14.16
249
2052
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
42
155
3.02
8.78
3.5
2.2
u/l
45.2
30.0
0.46
36
131
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
10
10.31
8.66
1.7
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
6
20.77
8.53
4.0
2.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
67
4.00
8.51
1.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
28
82
3.68
8.43
1.4
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
19
42
4.78
8.21
1.5
3.1
mmol/l
27.4
43.5
1.62
19
42
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
26
74
3.77
8.15
1.3
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
20
6.76
8.10
1.5
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
11
5
22.76
8.06
2.5
2.0
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
12
17
7.32
8.02
1.9
3.4
umol/l
1.1
1.1
0.04
12
17
(40761511) CBC panel - Blood by Automated count
247
2057
3.75
8.02
30.9
6.4
—
—
—
0
0
(3020891) Body temperature
19
43
4.66
7.99
17.1
6.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
31
102
3.30
7.83
15.5
2.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
156
1074
2.08
7.77
4.2
2.1
mmol/l
5.3
5.4
1.62
150
962
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
19
45
4.45
7.57
1.1
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
29
5.40
7.50
1.1
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
0
+∞
7.31
4.0
0.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
5
20.61
7.17
15.7
22.4
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
10
5
20.61
7.17
1.6
1.0
pmol/l
5.9
—
—
5
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
16
7.10
7.17
1.9
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
13
7.92
7.13
1.3
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
13
7.92
7.13
1.3
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
13
7.92
7.13
1.3
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
13
7.92
7.13
2.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
47
206
2.55
7.06
5.8
4.0
mg/l
234.9
148.7
0.42
41
168
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
45
194
2.58
6.99
4.2
2.1
ng/l
74.1
31.1
0.45
29
65
(3019309) Folate [Moles/volume] in Red Blood Cells
22
62
3.76
6.99
1.4
1.5
nmol/l
1357.1
1113.2
0.53
17
47
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
28
5.20
6.75
1.6
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
45
4.20
6.70
8.1
2.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
0
+∞
6.26
3.2
0.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
6
0
+∞
6.26
3.2
0.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
10
8
12.88
6.12
1.9
2.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
22
68
3.42
6.11
5.4
1.8
umol/l
40.6
30.1
1.64
22
60
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
10
16
6.43
5.97
1.3
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
54
3.70
5.96
35.3
11.8
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
21
65
3.41
5.82
34.3
12.3
%
0.7
0.7
0.32
21
65
(3014007) Fractional oxyhemoglobin in Arterial blood
21
66
3.36
5.69
34.3
12.2
%
93.5
95.6
0.57
21
66
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
7
13.20
5.61
4.3
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
94
591
1.90
5.60
1.8
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
64
353
2.06
5.54
18.0
3.2
estimate
0.0
0.0
0.00
33
110
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
25
4.96
5.52
1.2
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
5
16.36
5.43
13.9
4.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
27
102
2.82
5.39
2.0
1.4
g/l
0.2
0.2
0.15
27
97
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
245
2131
2.84
5.37
52.5
8.2
mg/l
19.6
24.8
2.63
215
1327
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
59
3.38
5.25
6.6
2.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
19
59
3.38
5.25
3.1
2.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
27
104
2.77
5.20
2.0
1.4
g/l
1.0
1.2
1.26
27
98
(3044290) Cell count panel - Cerebral spinal fluid
22
76
3.05
5.13
13.0
2.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
8
6
13.64
5.10
4.3
1.8
%
47.2
39.9
—
8
6
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
20
66
3.18
5.03
35.1
12.2
%
1.0
1.0
0.18
20
66
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
17
51
3.48
4.94
3.3
1.6
ug/l
10.1
6.6
0.33
11
39
(3013512) EKG study
35
158
2.39
4.91
4.7
2.9
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
12
28
4.42
4.85
10.7
5.2
ug/l
31.8
21.7
0.62
12
28
(3021879) Hepatitis B virus core Ab [Presence] in Serum
31
133
2.50
4.84
2.1
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
8
7
11.69
4.80
1.3
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
20
5.14
4.79
2.9
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
31
134
2.48
4.77
1.7
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
59
3.19
4.58
1.7
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
23
88
2.76
4.50
1.5
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
139
1039
1.70
4.33
2.7
1.7
g/l
1.5
1.5
0.21
96
440
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
9
9.08
4.30
1.9
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
58
337
1.91
4.26
15.9
2.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
43
228
2.05
4.09
3.3
1.6
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
8
10
8.17
4.08
1.1
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
21
81
2.72
4.05
13.9
2.7
mg/l
653.6
323.7
0.36
21
81
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
7
7
10.19
4.02
1.9
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
7
10.19
4.02
1.9
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
19
70
2.84
3.98
15.1
2.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
33
3.75
3.94
1.4
1.3
u/ml
2.6
4.0
—
7
21
(3004588) Protein electrophoresis panel - Serum or Plasma
8
11
7.43
3.87
1.1
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
75
490
1.73
3.73
16.6
2.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
12
6.81
3.69
3.6
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
16
5.76
3.68
2.0
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
42
3.19
3.39
1.9
1.3
—
—
—
0
0
(4062490)
15
53
2.93
3.39
1.6
1.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
10
7.13
3.37
2.1
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
11
6.48
3.19
1.9
2.2
u/ml
1405.7
1698.0
—
7
11
(3000330) Specific gravity of Urine by Test strip
15
56
2.77
3.09
4.4
2.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
6
8
7.61
3.06
1.2
1.6
u/l
9.9
28.1
—
6
8
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
45
2.97
3.05
1.5
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
12
5.94
3.03
1.4
1.1
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
5
10.12
2.98
1.4
2.8
mmol/l
107.2
106.4
—
5
5
(40763791) Oxygen content in Venous blood by calculation
5
5
10.12
2.98
6.4
24.8
ml/dl
13.7
13.3
—
5
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
5
10.12
2.98
1.4
2.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
17
4.80
2.93
1.4
1.0
—
—
—
0
0
(4306422)
9
22
4.18
2.90
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
59
2.62
2.82
1.7
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
18
4.53
2.80
1.4
1.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
6
8.43
2.75
1.4
2.5
mmol/l
4.6
3.9
—
5
6
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
14
5.08
2.73
1.3
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
14
5.08
2.73
1.3
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
14
5.08
2.73
1.3
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
99
742
1.52
2.70
4.0
2.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
6
10
6.09
2.70
1.5
1.7
umol/l
15.9
17.1
—
6
10
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
43
2.86
2.66
1.2
1.2
%
85.3
78.2
0.19
12
43
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
43
2.86
2.66
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
136
2.00
2.58
2.5
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
62
2.49
2.57
1.7
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
56
2.57
2.55
1.4
1.4
ug/g
367.0
374.3
—
7
32
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
11
5.53
2.55
1.3
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
33
3.10
2.53
1.5
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
56
377
1.61
2.42
13.1
2.7
kg/l
1.0
1.0
—
7
70
(42529406) Shigella sp [Presence] in Stool by Culture
15
64
2.41
2.41
1.7
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
12
5.07
2.40
1.5
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
8
6.32
2.37
1.0
1.1
—
—
—
0
0
(4268621)
8
22
3.70
2.37
2.3
2.3
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
7
17
4.18
2.36
1.6
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
18
3.95
2.26
4.1
1.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
7
18
3.95
2.26
6.4
3.4
mmol/l
1.9
1.4
—
7
18
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
19
3.74
2.15
1.6
1.8
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
6
14
4.34
2.15
1.2
1.2
%
71.7
74.5
—
6
14
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
6
14
4.34
2.15
1.2
1.2
mu/l
384.5
380.0
—
6
14
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
9
32
2.86
2.01
1.2
1.8
%
131.3
116.1
—
9
32
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
21
3.38
1.97
1.1
1.7
—
—
—
0
0
(3019225) pH of Specimen
12
51
2.41
1.96
15.3
4.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
11
4.59
1.94
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
11
4.59
1.94
1.2
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
5
11
4.59
1.94
3.0
1.5
u/l
2.2
2.3
—
5
6
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
27
3.01
1.94
1.8
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
33
2.78
1.94
3.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
22
3.23
1.88
1.1
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
20
108
1.91
1.85
1.5
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
195
1740
1.44
1.84
4.5
3.7
mu/l
2.1
2.0
0.83
190
1631
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
12
4.21
1.82
9.6
3.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
53
2.31
1.82
1.4
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
35
2.62
1.81
1.3
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
23
3.09
1.80
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
18
3.37
1.75
1.7
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
14
68
2.11
1.72
8.0
2.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
31
2.62
1.66
1.1
1.0
g/l
1.6
1.4
—
8
31
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
31
2.62
1.66
1.5
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
27
2.62
1.52
1.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
22
133
1.71
1.46
4.2
1.7
mmol/l
2.4
2.4
0.28
22
100
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
16
3.15
1.44
1.4
1.4
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
6
22
2.76
1.43
1.2
1.2
%
70.8
93.5
—
6
22
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
7
29
2.44
1.39
1.6
2.1
u/ml
55.9
30.1
—
7
29
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
29
2.44
1.39
1.6
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
12
62
1.97
1.28
2.1
1.6
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
18
2.80
1.28
1.8
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
18
2.80
1.28
1.8
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
377
0.65
1.25
1.1
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
36
2.25
1.25
1.3
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
18
109
1.69
1.21
4.4
2.1
e9/l
4.3
4.3
0.02
18
103
(3019832) Treponema pallidum Ab [Presence] in Serum
37
267
1.44
1.19
1.7
1.8
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
26
2.33
1.18
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
26
2.33
1.18
1.2
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
26
175
1.53
1.16
1.8
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
80
1.78
1.14
1.4
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
84
699
1.29
1.10
2.2
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
81
1.76
1.10
1.3
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
190
1.46
1.00
1.4
1.2
iu/ml
11.1
24.1
—
7
37
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
7
37
1.91
0.94
3.4
2.5
nmol/l
1.1
1.8
—
7
32
(3051387) C reactive protein [Mass/volume] in Capillary blood
6
27
2.24
0.94
5.5
2.8
mg/l
16.0
22.8
—
6
16
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
13
78
1.69
0.92
4.9
6.2
ug/l
1.6
2.0
0.45
13
78
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
104
0.47
0.91
1.2
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
18
121
1.52
0.84
1.4
1.4
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
6
32
1.89
0.82
1.0
1.3
—
33.4
—
0
9
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
23
2.19
0.76
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
131
0.60
0.75
1.3
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
39
1.81
0.73
1.1
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
39
1.81
0.73
1.1
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
25
2.01
0.73
1.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
40
1.76
0.71
1.3
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
40
1.76
0.71
2.3
1.8
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
26
1.93
0.71
1.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
26
1.93
0.71
1.0
1.0
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
86
1.53
0.66
1.2
1.3
u/ml
0.6
12.2
—
8
73
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
29
1.73
0.64
1.6
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
147
1.38
0.62
4.0
2.6
u/l
7865.5
3629.1
—
6
44
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
49
1.65
0.62
1.5
1.4
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
18
131
1.40
0.60
1.3
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
125
0.63
0.56
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
91
1.44
0.53
1.5
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
20
152
1.34
0.53
1.7
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
179
1.31
0.52
1.4
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
122
1129
1.14
0.47
2.4
2.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
82
0.60
0.46
1.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
49
1.43
0.46
1.1
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
49
1.43
0.46
1.1
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
49
1.43
0.46
1.1
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
49
1.43
0.46
1.1
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
8
55
1.46
0.43
1.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
5
32
1.57
0.42
2.2
2.2
ug/l
0.8
1.0
—
5
27
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.2
—
0.5
—
0
15
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
17
0.00
0.41
0.0
1.3
—
101.4
—
0
17
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
36
1.39
0.38
1.4
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
114
0.69
0.38
1.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
45
394
1.17
0.37
1.3
1.5
—
294.8
—
0
21
(3000492) Spirometry study
19
152
1.26
0.37
2.0
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
38
433
0.85
0.36
2.1
2.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
231
2249
1.18
0.36
4.3
3.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
82
1.35
0.34
1.8
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
97
0.71
0.31
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
107
1127
0.91
0.29
1.6
2.1
u/ml
0.9
5.4
—
10
164
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
1.3
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
19
225
0.83
0.28
1.7
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
36
402
0.88
0.27
2.1
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
19
223
0.84
0.26
1.7
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
223
0.84
0.26
1.7
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
95
1.27
0.26
1.3
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
211
0.84
0.25
1.7
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
220
0.85
0.23
1.7
2.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
39
1.28
0.23
4.0
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
93
0.74
0.23
1.0
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
22
251
0.86
0.22
1.0
1.2
u/ml
0.5
4.5
—
5
86
(3022670) pH of Venous cord blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
6
47
1.28
0.20
1.0
1.0
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
6
47
1.28
0.20
1.0
1.0
mmol/l
20.8
18.8
—
6
47
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
0
14
0.00
0.20
0.0
2.9
—
1.4
—
0
9
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
80
1.25
0.20
3.4
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
19
214
0.88
0.17
1.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
206
1.12
0.15
1.5
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
279
0.92
0.11
2.5
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
22
238
0.91
0.11
2.0
1.9
—
—
—
0
0
(4010399)
13
116
1.12
0.09
2.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
17
155
1.10
0.08
2.2
2.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
52
537
0.96
0.07
1.2
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
38
365
1.04
0.05
1.1
1.2
—
60.8
—
0
6
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
270
1.04
0.02
1.5
1.3
u/ml
0.7
3.2
2.12
20
189
(3028707) Methadone [Presence] in Urine by Screen method
13
123
1.06
0.01
1.7
2.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
111
0.99
0.00
1.1
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
26
256
1.01
0.00
1.2
1.3
u/ml
0.1
1.4
2.60
20
196
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
260
1.00
0.00
1.2
1.2
u/ml
0.5
7.2
8.46
20
206
(1001926) Buprenorphine [Presence] in Urine by Screen method
18
181
0.99
0.00
1.6
2.1
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
9.8
—
0
5
(4211845)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
9
0.00
0.00
0.0
1.0
—
12.4
—
0
9
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4146454)
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
3.0
—
0.3
—
0
5
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.9
—
0.4
—
0
8
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_MIH_CARIES and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MIH_CARIES.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: K11_MIH_CARIES – Molar incisor enamel hypoplasia, with caries

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data